These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20951144)

  • 1. Mathematical modeling of allergy and specific immunotherapy: Th1-Th2-Treg interactions.
    Gross F; Metzner G; Behn U
    J Theor Biol; 2011 Jan; 269(1):70-8. PubMed ID: 20951144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingual immunotherapy mechanisms of action: the role of Th1 response.
    Ciprandi G; Tosca MA; Marseglia GL
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):9-12. PubMed ID: 19944003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
    Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
    J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T regulatory cells in allergy.
    Braga M; Quecchia C; Cavallucci E; Di Giampaolo L; Schiavone C; Petrarca C; Di Gioacchino M
    Int J Immunopathol Pharmacol; 2011; 24(1 Suppl):55S-64S. PubMed ID: 21329567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine-modulated regulation of helper T cell populations.
    Yates A; Bergmann C; Van Hemmen JL; Stark J; Callard R
    J Theor Biol; 2000 Oct; 206(4):539-60. PubMed ID: 11013114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shift from Th2 to Th1 response in immunotherapy with venoms.
    Kosnik M; Wraber B
    Pflugers Arch; 2000; 440(5 Suppl):R70-1. PubMed ID: 11005617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific immunotherapy and turning off the T cell: how does it work?
    Ozdemir C; Kucuksezer UC; Akdis M; Akdis CA
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):381-92. PubMed ID: 22018608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
    Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A role for T-helper type 1 and type 2 cytokines in the pathogenesis of various human diseases].
    Kasakura S
    Rinsho Byori; 1998 Sep; 46(9):915-21. PubMed ID: 9800477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory activity of human CD4 CD25 T cells depends on allergen concentration, type of allergen and atopy status of the donor.
    Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
    Immunology; 2005 Sep; 116(1):103-11. PubMed ID: 16108822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell regulation in murine and human autoimmune diabetes: the role of TH1 and TH2 cells.
    Heurtier AH; Boitard C
    Diabetes Metab; 1997 Nov; 23(5):377-85. PubMed ID: 9416429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th1 and Th17 Predominance in the Enthesitis-related Arthritis Form of Juvenile Idiopathic Arthritis.
    Mahendra A; Misra R; Aggarwal A
    J Rheumatol; 2009 Aug; 36(8):1730-6. PubMed ID: 19531753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
    Jutel M; Akdis M; Blaser K; Akdis CA
    Allergy; 2006 Jul; 61(7):796-807. PubMed ID: 16792576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of allergen-specific immunotherapy: T-regulatory cells and more.
    Verhagen J; Blaser K; Akdis CA; Akdis M
    Immunol Allergy Clin North Am; 2006 May; 26(2):207-31, vi. PubMed ID: 16701141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of allergen-specific antibodies in allergy and specific immunotherapy.
    Blaser K; Akdis CA; Faith A
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1999; (93):243-51; discussion 252. PubMed ID: 11487881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell responses during allergen-specific immunotherapy.
    Maggi E; Vultaggio A; Matucci A
    Curr Opin Allergy Clin Immunol; 2012 Feb; 12(1):1-6. PubMed ID: 22157159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How instruction and feedback can select the appropriate T helper response.
    Bergmann C; van Hemmen JL; Segel LA
    Bull Math Biol; 2002 May; 64(3):425-46. PubMed ID: 12094404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells and asthma.
    Robinson DS
    Clin Exp Allergy; 2009 Sep; 39(9):1314-23. PubMed ID: 19538496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergen-specific T lymphocytes as targets for specific immunotherapy: striking at the roots of type I allergy.
    Bohle B
    Arch Immunol Ther Exp (Warsz); 2002; 50(4):233-41. PubMed ID: 12371619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
    Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
    Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.